Functional Insights into Silymarin as an Antiviral Agent against Enterovirus A71 (EV-A71)
Enterovirus A71 (EV-A71) is a major neurovirulent agent capable of causing severe hand, foot and mouth disease (HFMD) associated with neurological complications and death. Currently, no FDA-approved antiviral is available for the treatment of EV-A71 infections. The flavonoid silymarin was shown to e...
Main Authors: | Salima Lalani, Malihe Masomian, Chit Laa Poh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/16/8757 |
Similar Items
-
Antiviral activity of silymarin in comparison with baicalein against EV-A71
by: Salima S. Lalani, et al.
Published: (2020-03-01) -
Flavonoids as Antiviral Agents for <i>Enterovirus A71</i> (<i>EV</i>-<i>A71</i>)
by: Salima Lalani, et al.
Published: (2020-02-01) -
Enterovirus A71 Vaccines
by: Mei-Ling Li, et al.
Published: (2021-02-01) -
Valine/isoleucine variants drive selective pressure in the VP1 sequence of EV-A71 enteroviruses
by: Nghia Ngu Duy, et al.
Published: (2017-05-01) -
Dysregulated autophagy contributes to the pathogenesis of enterovirus A71 infection
by: Chuanjie Zhang, et al.
Published: (2020-12-01)